Literature DB >> 21860673

A key problem and challenge for hepatology: Obesity-related metabolic liver diseases.

Yasemin Hatice Balaban1.   

Abstract

With the arrival of the new millennium, gastroenterologists have been faced with the problem of metabolic liver diseases associated with obesity. The active role of the liver in metabolism and inflammation make it a key organ in the war against the rapidly-spreading world-wide epidemic of obesity. Many lives and much money could be saved if the work of hepatologists led to the development of effective diagnostic and therapeutic strategies against this growing leader of cirrhosis.

Entities:  

Keywords:  Adiposopaty.; Insuline resistance; Lipotoxicity; Metabolic liver diseases; Obesity; Steatohepatitis

Year:  2011        PMID: 21860673      PMCID: PMC3159494          DOI: 10.4254/wjh.v3.i6.142

Source DB:  PubMed          Journal:  World J Hepatol


  21 in total

1.  A 2020 vision for healthy people.

Authors:  Howard K Koh
Journal:  N Engl J Med       Date:  2010-05-06       Impact factor: 91.245

2.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

3.  What's in a NAme?

Authors:  Elizabeth M Brunt
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

4.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

Review 5.  Should nonalcoholic fatty liver disease be renamed?

Authors:  Paola Loria; Amedeo Lonardo; Nicola Carulli
Journal:  Dig Dis       Date:  2005       Impact factor: 2.404

Review 6.  Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection.

Authors:  Ira M Jacobson; Gary L Davis; Hashem El-Serag; Francesco Negro; Christian Trépo
Journal:  Clin Gastroenterol Hepatol       Date:  2010-08-14       Impact factor: 11.382

Review 7.  Obesity and diabetes: lipids, 'nowhere to run to'.

Authors:  Margaret J Hill; David Metcalfe; Philip G McTernan
Journal:  Clin Sci (Lond)       Date:  2009-01       Impact factor: 6.124

Review 8.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

Review 9.  Obesity, inflammation, and insulin resistance--a mini-review.

Authors:  Maximilian Zeyda; Thomas M Stulnig
Journal:  Gerontology       Date:  2009-04-08       Impact factor: 5.140

Review 10.  Obesity and overweight in Canada: an updated cost-of-illness study.

Authors:  A H Anis; W Zhang; N Bansback; D P Guh; Z Amarsi; C L Birmingham
Journal:  Obes Rev       Date:  2009-04-21       Impact factor: 9.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.